De With K, Schröder H, Meyer E, Nink K, Hoffmann S, Steib-Bauert M, Kämmerer R, Ruess S, Daschner F D, Kern W V
Medizinische Klinik und Poliklinik, Klinikum der Albert-Ludwigs-Universität, Freiburg.
Dtsch Med Wochenschr. 2004 Sep 17;129(38):1987-92. doi: 10.1055/s-2004-831838.
In view of increasing rates of antibiotic resistance worldwide and decreased research and development of new antibacterial compounds, programmes helping to better understand the complex relationship between antibiotic consumption and emergence of resistance have gained importance. Consequently, in addition to increased support for research projects that establish prospective surveillance and evaluation of antibiotic resistance and antimicrobial drug use, the EU has passed directives addressing political leadership in this respect. Information on antibiotic use in Germany is now available from databases independent from cost-oriented market research studies. This information allows estimation of antibiotic use in ambulatory and hospital care as compared with to other EU countries. According to results of current projects, the frequency of national antibiotic use in ambulatory care in Germany (4948 defined daily doses per 1000 population per year) falls within the lower third of EU countries. Upper boundaries in regional variation in antibiotic use are still much lower than values for high-use countries like France, Spain and Portugal. Hospital antibiotic use, in contrast, appears to be in the range of that reported for other countries. However, only rough estimates of hospital antibiotic use are available for Germany as well as most other EU countries due to data usually derived from non-representative hospital sampling.
鉴于全球抗生素耐药率不断上升以及新型抗菌化合物的研发减少,有助于更好地理解抗生素消费与耐药性出现之间复杂关系的项目变得愈发重要。因此,除了加大对建立抗生素耐药性前瞻性监测和评估以及抗菌药物使用研究项目的支持外,欧盟还通过了相关指令,在这方面发挥政治引领作用。目前德国抗生素使用信息可从独立于以成本为导向的市场研究的数据库获取。该信息能够估算德国门诊和医院护理中的抗生素使用情况,并与其他欧盟国家进行比较。根据当前项目结果,德国门诊护理中全国抗生素使用频率(每年每1000人口4948限定日剂量)处于欧盟国家的下三分之一。抗生素使用区域差异的上限仍远低于法国、西班牙和葡萄牙等高使用国家的值。相比之下,医院抗生素使用情况似乎与其他国家报告的范围相当。然而,由于数据通常来自非代表性的医院抽样,德国以及大多数其他欧盟国家仅能获得医院抗生素使用的粗略估计值。